Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy

Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy

US Patent 12497660 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for preprocessing target data and generating predictions usi2025
Systems and methods for preprocessing target data and generating predictions usi2025
Subtyping prostate cancer to predict response to hormone therapy2024
Subtyping prostate cancer to predict response to hormone therapy2024
Use of genomic signatures to predict responsiveness of patients with prostate ca2022
Use of genomic signatures to predict responsiveness of patients with prostate ca2022
Molecular subtyping, prognosis, and treatment of bladder cancer2021
Molecular subtyping, prognosis, and treatment of bladder cancer2021
Method and apparatus for controlling pitch of wind turbine in extreme turbulence2021
Genetic signatures to predict prostate cancer metastasis and identify tumor aggr2021
Genetic signatures to predict prostate cancer metastasis and identify tumor aggr2021
Cancer diagnostics using biomarkers2021